Related Experiment Video
Updated: May 25, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
[Stem cell transplantation in myelofibrosis].
Aura Toivari1, Maija Itälä-Remes, Marjut Kauppila
1Turun yliopisto.
Duodecim; Laaketieteellinen Aikakauskirja
|January 14, 2012
Summary
Allogeneic stem cell transplant (ASCT) offers a potential cure for myelofibrosis. Reduced-intensity conditioning improves safety, enabling ASCT for older patients with manageable outcomes.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Context:
- Myelofibrosis is a malignant myeloproliferative neoplasm.
- Allogeneic hematopoietic stem cell transplantation (ASCT) is the only potentially curative treatment.
- High transplant-related mortality remains a challenge.
Purpose:
- To evaluate the outcomes of ASCT with reduced-intensity conditioning in myelofibrosis patients.
- To assess the efficacy and safety of this approach in a clinical setting.
Summary:
- ASCT with reduced-intensity conditioning was performed on thirteen myelofibrosis patients between 1999 and 2009.
- This approach allows transplantation in older patients (up to 65-70 years) with reduced toxicity.
- Outcomes included a favorable response in about one-third of patients, disease progression in another third, and transplant-related mortality in the remaining third.
Impact:
- Reduced-intensity conditioning enhances ASCT safety and accessibility for myelofibrosis.
- ASCT offers a potentially curative option with manageable risks for select patients.
- Findings align with existing literature, supporting the role of ASCT in myelofibrosis management.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...